{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "ACE2 receptor",
      "SARS-CoV-2",
      "peptoids"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34445669",
  "DateCompleted": {
    "Year": "2021",
    "Month": "09",
    "Day": "07"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "08",
        "Day": "20"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "8963",
      "10.3390/ijms22168963"
    ],
    "Journal": {
      "ISSN": "1422-0067",
      "JournalIssue": {
        "Volume": "22",
        "Issue": "16",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug",
          "Day": "20"
        }
      },
      "Title": "International journal of molecular sciences",
      "ISOAbbreviation": "Int J Mol Sci"
    },
    "ArticleTitle": "\"Molecular Masks\" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry.",
    "Abstract": {
      "AbstractText": [
        "Coronavirus Disease 2019 (COVID-19) remains a global health crisis, despite the development and success of vaccines in certain countries. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, uses its spike protein to bind to the human cell surface receptor angiotensin-converting enzyme 2 (ACE2), which allows the virus to enter the human body. Using our unique cell screening technology, we identified two ACE2-binding peptoid compounds and developed dimeric derivatives (ACE2P1D1 and ACE2P2D1) that effectively blocked spike protein-ACE2 interaction, resulting in the inhibition of SARS-CoV-2 pseudovirus entry into human cells. ACE2P1D1 and ACE2P2D1 also blocked infection by a D614G mutant pseudovirus. More importantly, these compounds do not decrease ACE2 expression nor its enzyme activity (which is important in normal blood pressure regulation), suggesting safe applicability in humans."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-8230-4232"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacological & Pharmaceutical Sciences, University of Houston, 4849 Calhoun Rd, Houston, TX 77204-5037, USA."
          }
        ],
        "LastName": "Shukla",
        "ForeName": "Satya Prakash",
        "Initials": "SP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacological & Pharmaceutical Sciences, University of Houston, 4849 Calhoun Rd, Houston, TX 77204-5037, USA."
          }
        ],
        "LastName": "Cho",
        "ForeName": "Kwang Bog",
        "Initials": "KB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacological & Pharmaceutical Sciences, University of Houston, 4849 Calhoun Rd, Houston, TX 77204-5037, USA."
          }
        ],
        "LastName": "Rustagi",
        "ForeName": "Vineeta",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacological & Pharmaceutical Sciences, University of Houston, 4849 Calhoun Rd, Houston, TX 77204-5037, USA."
          }
        ],
        "LastName": "Gao",
        "ForeName": "Xiang",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biology and Biochemistry, University of Houston, 3455 Cullen Blvd, Houston, TX 77204-5037, USA."
          }
        ],
        "LastName": "Fu",
        "ForeName": "Xinping",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biology and Biochemistry, University of Houston, 3455 Cullen Blvd, Houston, TX 77204-5037, USA."
          }
        ],
        "LastName": "Zhang",
        "ForeName": "Shaun Xiaoliu",
        "Initials": "SX"
      },
      {
        "Identifier": [
          "0000-0003-3296-9177"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacological & Pharmaceutical Sciences, University of Houston, 4849 Calhoun Rd, Houston, TX 77204-5037, USA."
          }
        ],
        "LastName": "Guo",
        "ForeName": "Bin",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacological & Pharmaceutical Sciences, University of Houston, 4849 Calhoun Rd, Houston, TX 77204-5037, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "MD Anderson Cancer Center, Department of Cancer Systems Imaging, 1881 East Road, Houston, TX 77030-4009, USA."
          }
        ],
        "LastName": "Udugamasooriya",
        "ForeName": "D Gomika",
        "Initials": "DG"
      }
    ],
    "GrantList": [
      {
        "GrantID": "67176",
        "Agency": "University of Houston",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Int J Mol Sci",
    "NlmUniqueID": "101092791",
    "ISSNLinking": "1422-0067"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Peptoids"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "spike protein, SARS-CoV-2"
    },
    {
      "RegistryNumber": "EC 3.4.15.1",
      "NameOfSubstance": "Peptidyl-Dipeptidase A"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "ACE2 protein, human"
    },
    {
      "RegistryNumber": "EC 3.4.17.23",
      "NameOfSubstance": "Angiotensin-Converting Enzyme 2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Angiotensin-Converting Enzyme 2"
    },
    {
      "QualifierName": [
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "MCF-7 Cells"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Peptidyl-Dipeptidase A"
    },
    {
      "QualifierName": [
        "metabolism",
        "pharmacology"
      ],
      "DescriptorName": "Peptoids"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Protein Binding"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Virus Internalization"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}